Equanil en es it fr

Equanil Brand names, Equanil Analogs

Equanil Brand Names Mixture

  • No information avaliable

Equanil Chemical_Formula


Equanil RX_link

No information avaliable

Equanil fda sheet

Equanil msds (material safety sheet)

Equanil Synthesis Reference

No information avaliable

Equanil Molecular Weight

309.469 g/mol

Equanil Melting Point

< 25 oC

Equanil H2O Solubility

Soluble as HCl salt

Equanil State


Equanil LogP


Equanil Dosage Forms

Tablets (oral, 1 mg)

Equanil Indication

Used for the symptomatic treatment of parkinsonism.

Equanil Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Equanil Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Equanil side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Equanil Patient Information

Equanil Organisms Affected

Humans and other mammals